Anti-MFAP4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody that binds MFAP4 expressed on the surface of a subset of regulatory cells and anti-cancer cells. The activated regulatory cells can be used to treat or prevent the progression of many types of immune-related diseases, such as graft rejection, graft-versus-host disease, autoimmune disease, allergic diseases and infectious disease. The activated anti-cancer cells can be used to treat or prevent the progression of cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For research use only. Not intended for any clinical use.